BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 19268412)

  • 1. Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation.
    David S; Kümpers P; Hellpap J; Horn R; Leitolf H; Haller H; Kielstein JT
    Am J Kidney Dis; 2009 May; 53(5):770-8. PubMed ID: 19268412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular disease outcome and thrombocytosis in diabetic and nondiabetic end-stage renal disease patients on peritoneal dialysis.
    Sokunbi DO; Wadhwa NK; Suh H
    Adv Perit Dial; 1994; 10():77-80. PubMed ID: 7999869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of advanced glycation end products in children with renal disease.
    Sebeková K; Podracká L; Blazícek P; Syrová D; Heidland A; Schinzel R
    Pediatr Nephrol; 2001 Dec; 16(12):1105-12. PubMed ID: 11793110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence of atherosclerosis in renal transplant recipients].
    Japichino GG; Bonati L; Rubini P; Capocasale E
    Minerva Cardioangiol; 2001 Aug; 49(4):229-38. PubMed ID: 11426192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of cardiovascular disease in chronic renal disease.
    Foley RN; Parfrey PS; Sarnak MJ
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S16-23. PubMed ID: 11443763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prostatism in patients with chronic renal failure and in renal transplant recipients. Comparative study].
    Garcia Reboll L; Jiménez Cruz JF; Montserrat Monfort JJ; Sánchez Plumed J; Pallardo L
    Actas Urol Esp; 1996 Sep; 20(8):690-6. PubMed ID: 9019942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating type VI collagen and undulin, in patients with kidney diseases, after kidney transplantation and on hemodialysis.
    Marder K; Keller F; Schuppan D
    Clin Nephrol; 1995 Sep; 44(3):178-84. PubMed ID: 8556834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural anti-alpha-galactosyl antibodies in patients undergoing peritoneal dialysis and hemodialysis.
    Pérez Fontán M; Máñez R; Blanco F; Rodríguez-Carmona A
    Adv Perit Dial; 2000; 16():216-8. PubMed ID: 11045297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anticardiolipin antibodies in hemodialysis patients and in renal transplant recipients: prevalence and significance].
    Ferlazzo B; Barrile A; Bonanno D; Quattrocchi P; Santoro D; Savica V; Bellinghieri G
    Recenti Prog Med; 1998 Sep; 89(9):434-7. PubMed ID: 9796372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Kidney diseases in the elderly from the internal medicine viewpoint. Diagnosis and therapy].
    Verwiebe R; Knauf H
    Fortschr Med; 1995 Oct; 113(29):418-22. PubMed ID: 7498873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of hemodialysis on selenium blood levels.
    Krízek M; Senft V; Motán J
    Sb Lek; 2000; 101(3):241-8. PubMed ID: 11220152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quality of life in children and adolescent with end-stage renal disease treated with dialysis and kidney transplantation].
    Rubik J; Grenda R; Jakubowska-Winecka A; Dabrowska A
    Pol Merkur Lekarski; 2000 Apr; 8(46):280-1. PubMed ID: 10897650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endocrine changes and sexual dysfunction in kidney transplantation and hemodialysis: comparative study].
    Rodríguez Rodríguez R; Burgos Revilla FJ; Gómez Dosantos V; Galbis Sanjuan F; Navarro Antolín J; Allona Almagro A; Orofino Azcue L
    Actas Urol Esp; 1996 Sep; 20(8):697-701. PubMed ID: 9019943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating soluble CR1 (CD35). Serum levels in diseases and evidence for its release by human leukocytes.
    Pascual M; Duchosal MA; Steiger G; Giostra E; Pechère A; Paccaud JP; Danielsson C; Schifferli JA
    J Immunol; 1993 Aug; 151(3):1702-11. PubMed ID: 8335953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New kidney, but a sick heart. Why many patients with renal failure and kidney transplant patients die of cardiovascular disease].
    Olbricht CJ
    MMW Fortschr Med; 1999 Oct; 141(43):34-6. PubMed ID: 10912119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Causes and risks of hyperlipidemia during dialysis and after renal transplantation].
    Verzola A; Perini L; Gatto S; Gilli P; Bedani PL
    Recenti Prog Med; 1998 Nov; 89(11):590-7. PubMed ID: 9844447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated body lead burden from drinking water in end-stage chronic renal failure.
    Kessler M; Durand PY; Hestin D; Cao Huu T; Renoult E; Prenat E; Chanliau J; Kaminski P; Duc M
    Nephrol Dial Transplant; 1995; 10(9):1648-53. PubMed ID: 8559484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alpha 1-antitrypsin level in serum of dialyzed and renal transplant patients (author's transl)].
    Zazgornik J; Kopsa H; Schmidt P; Pils P; Balcke P; Hysek H; Deutsch E
    J Clin Chem Clin Biochem; 1980 Apr; 18(4):241-4. PubMed ID: 6770031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morphologic changes in the esophagus in chronic hemodialysis and after kidney transplantation].
    Aliev MA; Ismagilov RZ; Fedotovskikh GV; Potanpov VA; Adil'gireeva LKh
    Arkh Patol; 1993; 55(6):36-9. PubMed ID: 8122973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrin levels in chronic renal failure, hemodialysis and renal transplant patients.
    Gokal R; Kettlewell M; Drexler E; Oliver DO; Morris PJ
    Clin Nephrol; 1980 Aug; 14(2):96-7. PubMed ID: 6996881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.